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SUMMARY
In this paper, the determinants of growth of aggregate health expenditures are investigated. The study departs
from previous literature in that it looks at differences across countries in growth (and not levels) of health care
expenditures. Estimation is made for 24 OECD countries. Health system characteristics usually believed to
influence health expenditures growth, like population ageing, the type of health system (public reimbursement,
public contract or integrate) and existence of gatekeepers, are found to be non-significant. Nevertheless, there is
evidence that health expenditures experienced a clear slower growth in the last decade. The explanation for this
slowdown could not be found in the proposed model and should stimulate further research. © 1998 John Wiley
& Sons, Ltd.
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INTRODUCTION
The health economics literature has seen, over the
last two decades or so, a considerable number of
studies trying to explain cross-country variations
in health spending. Better databases have allowed
for increased sophistication of analysis and more
robust inferences (and policy implications). A
good example of this line of research is found in
Gerdtham et al. [1], which summarizes in a very
clear way previous contributions and uses a larger
pooled sample to perform new hypothesis tests.
However, surprisingly enough no attention has
been given to explanations for health care expen-
ditures growth differences across countries. This
paper contributes (at least, partially) to a better
understanding of growth in health care expendi-
tures on the basis of cross-country and time-series
variations. It is argued that existing literature on
explanations of cross-country differences in health
care expenditures and the relative success of dis-
tinct health systems in cost-containment must be
complemented with studies looking directly at
growth rates of health care expenditure and its
determinants. The analysis should, therefore, be
understood as complementary to previous studies
of level differences in health spending.
On theoretical grounds, the analysis of expendi-
ture level differences explains what factors charac-
terize less costly health care systems at a certain
point in time, while analysis of growth rates indi-
cates which systems favour a greater growth of
health spending (even if the system converges to a
lower steady-state value than other systems).
Policy recommendations on health system orga-
nization should not be based solely on studies on
the level of health care expenditures. Understand-
ing the pace of growth of health spending can be
as important as understanding of level differences
across health systems. For example, the analysis
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in levels may find that certain characteristics of
health systems favour lower costs. However, to
say it also implies a lower growth rate is a differ-
ent matter.
A study somewhat close to this paper is due to
Newhouse [2]. Newhouse presents a health expen-
ditures growth accounting analysis for the US. He
concludes that about 50% of the increase in costs
could not be explained by traditional factors and
attributed it to technological progress.
The methodology of analysis is borrowed from
recent empirical growth theory, namely works
focusing on convergence. (Barro and Sala-i-Mar-
tin [3] provide a review of the most important
studies in chapters 11 and 12.) It should be
stressed that health-related variables (typically life
expectancy type of variables) have been employed
as regressors in GDP growth equations. Also,
there is empirical evidence on the link between life
expectancy at birth and GDP levels, where a
positive but decreasing relation between life ex-
pectancy and per capita GDP is found. (See Barro
and Sala-i-Martin [3], chapter 12.) There is, how-
ever, no received knowledge on the contribution
of GDP growth to health expenditures growth.
Therefore, we depart from the new growth empir-
ical studies in this respect.
Before proceeding to the analysis and in order
to motivate the reader, it is useful to look at
dispersion of health expenditures per capita and
how it has evolved over the least three decades.
Only the countries for which a complete data set
is available are included. There was, in the past 30
years, an increase in dispersion (measured by the
S.D. in health expenditures per capita), showing
that countries are moving apart on this matter.
However, average health expenditures per cap-
ita have also increased substantially, making the
ratio of S.D. over the mean fairly stable since the
mid 1970s (Figure 1), with a slight downward
trend. From 1960 to 1975, there is a clear decrease
in relative dispersion across countries. The same
evolution pattern occurs in the dispersion of the
share of health care expenditures on GDP, even if
S.D. over the mean has remained stable. Compu-
tation of regressions of each variable on a con-
stant term and a time trend, gives statistical
support to the assertions made.
These basic stylized facts pose two interesting
questions for researchers to answer. First, what
causes this dispersion across countries (GDP level,
characteristics of health systems, etc.)? The exist-
ing literature has mainly addressed this issue.
Second, what lies behind the upward trend in
health care expenditures and what are the best
arrangements to act upon it? This question has
seldom been analyzed and motivates the present
paper.
Cost-containment goals are at the heart of
most, if not all, reform proposals in the OECD
countries (see OECD [7]). A recurrent theme in
the literature is the relative success of different
organizational frameworks for health care sys-
tems. Hence, it seems desirable to test which
systems did promote a lower rise in health care
expenditure. This test may yield different results
from hypothesis tests based on levels of health
care spending. It can be the case that for some
structural reason a country has, at a given point
in time, a higher level of health care expenditure,
without any relation to the health system in place.
In cross-country level analysis this effect may be,
at least partially, attributed to the type of the
health system instead of being identified with
country characteristics. The recent work of
Gerdtham et al. [1,4,5] deals with this issue in a
different way. The use of pooled, cross-section
time-series data in expenditure levels, with enough
data in both dimensions, allows for the identifica-
tion of country-specific effects in their work. Of
course, these are not the only studies. Another
example of work on this line is due to McGuire et
al. [8].
The distinction between determinants of level
and growth of health expenditures is by no means
a trivial one. It is not possible, a priori, to estab-
Figure 1. Ratio of standard deviation over average value.
© 1998 John Wiley & Sons, Ltd. Health Econ. 7: 533–544 (1998)
HEALTH CARE EXPENDITURE DETERMINANTS 535
lish a unique link saying that factors explaining
cross-countries and over-time differences in the
level of health care expenditures should also be
the relevant ones to explain differences in growth
rates. A health system that has a lower level of
health expenditures may experience faster growth,
for example. Also, health systems that performed
relatively well in the sense of keeping health care
spending at a low level may (or may not) be more
vulnerable to growth, in a changing socio-eco-
nomic environment. Systems that perform better
in a certain moment may become, in the future,
dominated.
Despite the small sample size our approach
reveals some interesting results which, we hope,
will stimulate further research. In particular, we
found that the type of the health system, existence
of a gatekeeping procedure and ageing of popula-
tion are unable to explain average growth rates of
health care expenditures. This leaves largely unex-
plained the slowdown in growth rates observed in
the 1980s.
The paper is organized as follows. The second
section describes the methodology followed. Next,
the third section discusses the database used. The
fourth section presents the empirical results. Fi-
nally, the fifth section concludes.
METHODOLOGY
The aim of the paper is quite simple, and so is the
empirical approach followed. Due to the small
sample size, only a limited number of hypothesis
can be tested. We focus on health system features
that may have contributed to cost-containment.
Judging cost-containment measures is a tricky
business. Besides evaluating whether or not cost-
containment measures are desirable (or to which
extent should be pursued), targeting a value for
health care expenditures is more a political issue
than an economic one. Nevertheless, evaluation of
effectiveness of such measures (let aside efficiency
considerations for the time being) is warranted. If
such evaluation is made on a cross-section basis
alone, it is probably not possible to tell what is
due to reforms and measures undertaken and
what should be attributed to other factors (like
country characteristics). Looking at growth rates
of health care expenditures and their determinants
yields, potentially, useful knowledge on this
ground.
The first hypothesis to be tested is whether or
not those countries that already spent relatively
more in health care were also the ones where
expenditure grew more.
The dissemination of medical knowledge (which
is made at an increasingly faster pace) and wide
availability of new drugs and equipment suggests
that countries may experience a tendency to have
similar per capita expenditures. (This notion is
close to the concept of b-convergence in growth
theory. Note, however, that the reasoning under-
lying convergence theories cannot be applied to
health care expenditure.) If this holds true, one
should observe a higher growth rate in countries
with initial lower expenditures level as they catch
up with other countries. To test for the presence
of a significant impact of the starting point, be-
ginning of period values of the dependent variable
are included in the econometric specifications.
Another important factor for health expendi-
ture growth is, probably, GDP growth. In cross-
country explanations of health care expenditure
differences, GDP has been singled out as the most
important explanatory variable. In fact, empirical
studies systematically found that GDP accounts
for more than 90% of the observed variation.
Thus, cast in terms of growth rates, a positive
association between GDP growth and health ex-
penditure growth is expected.
Institutional features of health systems may
influence health care expenditures growth rate.
For example, fee-for-service rules do imply, in
general, higher expenditures in health care than
capitation schemes. Nonetheless, we cannot state
that growth rates of health care expenditures will
differ substantially in both systems.
To test for the importance of institutional ar-
rangements on growth of health care expenditures
two characteristics of health systems were in-
cluded as possible determinants. The first is the
OECD characterization of the health system as
public reimbursement, public contract or public
integrated. The second is the use of physicians:
general practitioners as gatekeepers in the system.
Traditionally, ageing of population is pointed
out as an important factor in rising health spend-
ing. The argument states that as people get older
more health care will be delivered to them. Ac-
cordingly, a variable accounting for the ageing of
population is also considered. Some recent work
has seriously challenged this view [8–10]. How-
ever, to our knowledge, it has not been tested if
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demographic evolution (ageing of population,
more precisely) has any bearing on the growth of
overall health care spending. Existing studies es-
sentially look at spending for different age co-
horts and are based on micro data. The main
finding is that population ageing is of less impor-
tance for health care expenditures than usually
held. Ageing has a strong impact on other aspects
of the welfare state, like retirement pensions.
Some extrapolation to health care services of this
demographic pressure may have been made. Our
direct test on growth rates complements these
earlier studies.
The role of government financing has gener-
ated some controversy, as both positive and neg-
ative effects on total health care expenditure have
been reported. Gerdtham et al. [1] provide a
useful discussion of the empirical findings. More-
over, Gouveia [11] has argued, theoretically and
empirically, against the notion of perfect substitu-
tion of public and private health care expendi-
tures. This suggests the inclusion of the pro-
portion of state-financed expenditure as a regres-
sor to investigate whether or not systems with a
larger state financing have experienced higher ex-
penditures growth. A pioneer study on the rela-
tion between the share of public expenditure in
health and spending levels is due to Leu [12]. Our
approach gives a panel data structure to the anal-
ysis and time (decade) specific effects are added
to the econometric specification. The panel data
structure of the sample also allows for the intro-
duction of country-specific effects but the small
time dimension makes overall estimates reflect
essentially cross-country differences, rendering
imprecise estimates of the country effects. There-
fore, we do not compute country-specific effects.
Since our interest lies in expenditure growth
over time, the dependent variables are average
growth rates over a decade. Three decades—
1960–1970, 1970–1980 and 1980–1990—are
considered. The decision to use growth rates over
a decade is, of course, open to criticism. There is
a clear cost relative to alternatives like year-to-
year or 5-year average growth rates: it consumes
degrees of freedom. On the other hand, lower-fre-
quency average growth rates have disadvantages
of their own. The most important one is that
some variables used in the analysis move slowly
over time. Decade-wide averages capture broad
trends instead of short-term variations, which
would become more important sources of varia-
tion if shorter period averages were considered.
Computation of the basic model with 5-year av-
erage or year-to-year growth rates have the same
qualitative results. The interested reader can find
these estimates in Appendix B.
Besides growth analysis of health care expendi-
tures, determinants for level differences are also
investigated as a check for the data used. In this
case, pooled data cover four points in time (1960,
1970, 1980 and 1990). The results are then dis-
cussed with reference to existing studies, espe-
cially the recent work of Gerdtham et al. [1].
THE DATA
All variables are extracted from the CREDES-
OECD database [13]. The data set covers 24
OECD countries, although for longer periods
non-availability of information dictates exclusion
of some countries in the first two decades.
The set of countries in the sample is consti-
tuted by Australia, Austria, Belgium, Canada,
Denmark, Finland, France, Germany, Greece,
Iceland, Ireland, Italy, Japan, Luxembourg, The
Netherlands, New Zealand, Norway, Portugal,
Spain, Sweden, Switzerland, Turkey, the UK and
the US.
The dependent variable used is per capita
health expenditure growth, averaged across a
decade. This variable is valued at constant 1990
prices (in national currency units) and converted
to the same basis by PPPs at the base year. (The
same procedure was followed in Gerdtham et al.
[1].) An alternative dependent variable would be
the average growth of health expenditures over
GDP. However, in growth regression equations,
the two alternative dependent variables are linked
by a simple linear transformation and, therefore,
we should expect similar results from the analy-
sis. The growth rate of the share of health care
expenditures on GDP is equal to the growth rate
of per capita health expenditures minus the
growth rate of per capita GDP, which should be
included as an explanatory variable (if the depen-
dent variable is per capita health spending). It is
thus clear that the empirical specifications are
essentially the same when cast in terms of growth
rates. Note this is not true for analysis in levels of
health care expenditures.
The explanatory variables are constructed as
follows:
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 To reflect initial conditions, the dependent
variable evaluated at its level value in the first
year of the period is included. This variable is
denoted by TE per capita–T for per capita
expenditures;
 A dummy variable controls for the existence of
gatekeeping, GK. It assumes value 1 if the
system has gatekeepers, zero otherwise. The
countries for which gatekeeping is considered
are Austria, Canada, Denmark, Germany, Ice-
land, Ireland, Italy, The Netherlands, New
Zealand, Norway, Portugal, Spain and the
UK. The remaining countries are Australia,
Belgium, Finland, France, Greece, Japan, Lux-
embourg, Sweden, Switzerland, Turkey and the
US;
 Two dummy variables reflect the system’s type:
PR for public reimbursement (Australia, Bel-
gium, France, Italy (up to 1978), Japan, Lux-
embourg, Switzerland and US) and PI for
integrated (Denmark, Finland, Greece (from
1983), Iceland, Ireland, Italy (from 1979), New
Zealand, Norway, Portugal (from 1978), Spain
(from 1984), Sweden and the UK). The remain-
ing case is the baseline system, public contract
(Austria, Canada, Germany, Greece (up to
1982), The Netherlands, Portugal (up to 1977),
Spain (up to 1983) and Turkey). For those
countries which recently (last two decades)
changed the nature of the system the procedure
was to include them in the system to which
they belong most of the period. This definition
of systems’ types follows the characterization
of OCDE. It is, of course, open to criticism.
Health systems are sufficiently complex and
diversity of institutional arrangements suffi-
ciently large to make it impossible to have a
simple, manageable, classification that is uni-
versally accepted. Instead of engaging in the
debate over the proper classification, we opt to
use the one of OECD;
 The income variable employed is GDP average
growth rate over the period, GDPGR ;
 ageing of population is measured simply by the
change in the percentage of population over 65,
AGE65;
 Dummies variable for the decades 1970–1980
and 1980–1990, respectively D7080 and D8090,
are also included. Each of the variables takes
value 1 if the observation belongs to the
decade, zero otherwise. The decade 1960–1970
is taken as the baseline case. This procedure
corresponds to fixed time effects.
 The role of state-financed expenditures is prox-
ied by the share of state financing on overall
health care expenditures, as in previous work.
Summing up, the equation to be estimated has
the linear form
y; iaXiei (1)
where y; i denotes growth rate of yi, Xi denotes the
vector of exogenous variables described above
and ei is an error term following a NID(0, s2)
process. Results for a log–log form are essentially
the same. For regressions in levels, the double
logarithmic form has performed better (Gerdtham
et al. [4]). Since results do not differ qualitatively
from the linear specification, the latter is retained
(regressions not shown).
RESULTS
Table 1 presents the estimated effects of exoge-
nous variables on growth of total health care
expenditure (per capita). The first column pre-
sents the preferred specification. Substantial ex-
perimentation with the model resulted in several
simplifications. Individual and joint significance
tests were performed using likelihood ratio tests.
From the factors outlined, the dummy variable
for the decade 1980–1990 and GDP per capita
have a significant impact.
The other significant effect reveals that coun-
tries with a higher health care expenditure per
capita experienced a lower rate of growth. The
introduction of the quadratic term on the initial
value of expenditure per capita was dictated by
the misspecification tests conducted (see below).
The quadratic term allows for a non-linear effect
of the starting point of each country, which per-
forms significantly better than a linear approxi-
mation. All the other effects are qualitatively
unchanged by this term. The effect of the initial
level of health care spending is always negative.
That is, the higher the health care expenditures
per capita the lower is the growth rate in the next
decade (holding other factors constant). This sug-
gests the existence of some convergence among
countries. The absolute effect is stronger for heav-
ier spenders, although at a decreasing rate. In
fact, for the biggest spenders in the sample, the
marginal effect is essentially zero (see Table 2).
(The minimum occurs for a health expenditure of
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Table 1. Results for growth rate equations
Growth rate of health expenditures per capita
Constant 7.62 7.61 7.94 5.84 4.51
(6.45) (6.10) (4.93) (3.52) (4.23)
GDPGR 0.62 0.65 0.65 0.85 0.92
(3.69) (3.82) (3.35) (3.73) (4.69)
PR 0.24 0.56
(0.31) (0.07)
PI 0.04 1.62
(0.01) (0.22)
GK 0.36 0.71
(0.57) (1.21)
D8090 0.89 0.51 0.92
(1.86) (0.49) (0.01)
D7080 0.48 0.09
(0.57) (0.10)
AGE65 0.27 0.31
(1.15) (1.15)
PUBFIN 0.02 0.07
(0.11) (0.39)
TE per capita–T 0.096 0.102 0.099 0.033 0.035
(4.34) (4.65) (3.75) (2.80) (3.51)
(TE per capita–T)
2 0.037 0.037 0.036
(2.96) (3.24) (2.70)
Adjusted R2 0.704 0.710 0.688 0.417 0.627
Number of obs. 65 65 65 65 65
The values shown in parenthesis are t-ratios, based on White’s robust S.E.s.
1300.) At the highest values in the sample, the
relation exhibits already a positive marginal ef-
fect. It is, however, rather small (the maximum
value is not even a S.E. way from a zero value).
These figures corroborate the inference that a
catching-up effect in health care expenditures
seems to exist, as countries tend to converge to
similar per capita spending levels.
The negative sign associated with the dummy
variable D8090 shows that in the 1980s a common
trend to the OECD countries was a lower growth
rate. This may be due to cost-containment efforts,
which had some success relative to growth in the
previous two decades. OECD [7] describes mea-
sures undertaken in a selected sample of OECD
countries. Since none of the other proposed ex-
planatory variables turn out to be significant, the
slowdown in the growth rate remains largely un-
explained. The identification of factors that suc-
cessfully contributed to a lower growth of health
care expenditure should be pursued in future
research.
The non-significance of all other variables
means that, apparently, the existence of gatekeep-
ers or the type of health system (public reimburse-
ment, public contract or integrated) have played
no significant role to contain health expenditure
Table 2. The effect of initial conditions
Marginal effect of Initial values
initial values
Maximum 0.010 1435.000
Minimum 0.091 53.389
Average 0.047 664.945
S.D. 362.9580.027
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growth. This finding suggests that the type of
health system may have implications for the ex-
planation of the level of health care expenditures
across countries, but not on growth rates. The
main specifications were also estimated separately
for each time period. No change in the qualitative
inferences has resulted from the exercise.
On the other hand, ageing of population and
the relative size of state financing have not con-
tributed to growth of health spending. The first
finding runs against common wisdom but it is in
line with previous studies, which have found no
significant impact of population ageing [9,10].
Another interesting result was that economy’s
growth, measured by per capita GDP growth, had
a significant bearing on health expenditure in-
creases. This suggests an income elasticity lower
than but close to unity, which is not far apart
from existing estimates.
A final word with respect to the adjusted R2.
Irrespective of whether the obtained value should
be considered high or low, it is worth noting that
the unexplained residual amounts to roughly 30%.
This is below Newhouse’s [2] estimate of a techno-
logical progress residual in health care rising costs
in the US. Since no control for technology pro-
gress was made, we cannot exclude expensive new
technology as the main driving force behind
health expenditures growth, carrying onto inter-
national comparison of health care systems the
same consideration that have been put forward by
Newhouse for the US. Of course, many other
factors may be lying behind this finding. Future
research, as better data becomes available, should
improve our understanding of the role of techno-
logical change. It is not claimed that technology is
accountable for the large residual. It is, however,
the case that our results do not run against an
important role of technology in the growth of
health care spending.
The somewhat striking results obtained strongly
advises to perform some misspecification tests.
The application of the RESET test in the pre-
ferred linear specification has led to the inclusion
of quadratic terms of exogenous variables. After
extensive testing of individual and joint signifi-
cance, the maintained specification is presented in
the first column of Table 1. A description of the
tests performed, as well as further information on
the results can be found in Appendix A. Essen-
tially, the qualitative results show robustness
across specifications, the major difference being
Table 3. Results for level equations
Health expenditures per
capita
63.3335.12Constant
(0.32) (0.65)
GDP 0.106 0.108
(20.19) (24.70)
GK 15.45
(0.30)
PI 13.00
(0.24)
121.5514.73PR
(1.71) (2.82)
AGE65 4.78
(0.50)
PUBFIN 6.38 6.18
(3.75) (4.75)
Adjusted R2 0.877 0.880
89Number of obs. 89
The values shown in parenthesis are t-ratios based on
robust S.E.s.
the introduction of a quadratic term on the initial
value of health expenditures. Additional tests for
non-normality of error terms and exogeneity of
GDP growth were also performed, and the null
hypothesis was not rejected in either case. Ap-
pendix A describes in more detail the procedures
and the results of the tests.
To check for consistency of our database with
earlier studies, regressions on pooled data for
cross-country level differences in health care
spending ratio to GDP are presented in Table 3.
These regressions are based on variables observed
in four points in time: 1960, 1970, 1980 and 1990.
In these regressions no time or country-specific
effects were included. The results are in line with
previous studies. The most important single expla-
nation factor is GDP. The other significant effect
is the public reimbursement dummy. A final joint
significance test was performed. The null hypothe-
sis of zero coefficients for all omitted variables is
not rejected at the usual significance levels. Its
negative sign indicates that countries with a public
reimbursement system were able to have a lower
fraction of GDP devoted to health care expendi-
ture. No difference was found between the public
contract and the integrated system. Unlike the
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previous model, no misspecification tests were
performed. This is justified by the objective of
sticking as close as possible to earlier work on
level differences across countries in total per
capita health spending.
The result is in contradiction with the earlier
study of OECD [14], which has found that pub-
lic reimbursement systems are more expensive
than public contract or integrated systems.
On the other hand, the recent study of
Gerdtham et al. [1] presents the same qualitative
results. Our estimates show that Gerdtham et
al.’s [1] findings of public reimbursement being
the least costly system is robust to larger time-
dimension variation. Since variables present in
this type of studies evolve slowly over time, the
cross-section times-series data for contiguous
years tends to reflect essentially the cross-coun-
try variation. Our approach of using observa-
tions spaced in time (decade) allows time
variation to play a bigger role in determining
estimates.
In addition, we have the negative effect of
public financing of health case services, which
was a result already present in Gerdtham et al.
[1]. The effect results from budgetary pressures
on most OECD countries. In fact, public financ-
ing of health expenditures as a share of total
expenditures has decreased in most countries but
so have the weight of public health expenditures
on government’s budget. (The correlation coeffi-
cient between change in public health expendi-
tures as a fraction of total health expenditures
and as a fraction of total public expenditure is
about 0.6.) This suggests that priority setting at
the budget table is probably the explanation for
this effect (which does not correspond to a gen-
eral trend of lower role for the public sector).
As in growth rate analysis, the presence of
gatekeepers and ageing of population have no
explanatory power of health care expenditures.
Overall, these estimates are qualitatively simi-
lar to the ones present in recent studies, suggest-
ing that no significant bias emerges from the
database used and that results on growth rates
will probably hold in other data sets as well.
FINAL REMARKS
Making inferences about health care expenditure
patterns, based on broad aggregates over coun-
tries and time, is risky, especially if they are not
in accordance with received wisdom of previous
work. Hence, results should be interpreted
carefully.
Using decade-average growth to isolate the
analysis from short-run random influences, we
found that variables believed to influence health
expenditures increases are essentially non-
significant.
This is a mix of good news (as it corroborates
earlier findings for the effects of ageing popula-
tion) and bad news (as gatekeepers are usually
seen as a way to achieve cost-containment).
We detect, nevertheless, a clear slowdown in
health care expenditures (as GDP share) growth
in the decade 1980–1990 relative to the average
evolution in the two previous decades. The de-
terminants of this slowdown are not identified
by our model and the issue clearly calls for fur-
ther research.
These seemingly ‘negative’ results are not
contradictory with existing analysis of determi-
nants of health care expenditure (in levels). This
is true both on empirical and theoretical
grounds.
On the empirical side, we performed typical
estimations in levels, which gave qualitative re-
sults consistent with those of, for example,
Gerdtham et al. [1].
Combining both types of investigation—level
differences and growth rates—we may say that
even if some systems were able to sustain a
lower spending in health care, increases in ex-
penditures have hit in a roughly similar way all
systems (thus preserving the level differences be-
tween countries). This also gives a partial justifi-
cation to why panel data analysis embodying
contiguous yearly observations may yield esti-
mates consistent with pure cross-section studies.
The analysis is a little more refined than this, as
initial position is negatively related to growth.
That is, more costly systems tended to grow
less. The magnitude of the effect is, however,
small.
Finding the determinants of expenditure
growth should, therefore, receive more attention
from researchers and politicians, as it proved to
be no easy matter and do not constitute
straightforward extensions of studies on the
cross-country variation in the level of health
care expenditures.
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APPENDIX A: SPECIFICATION TESTS
The RESET test
A simple RESET test was applied to test for
misspecification in the functional form. The RE-
SET test assumes that the effect of omitted vari-
ables can be proxied by some function of the
original regressors. Being the function unknown,
a polynomial approximation with coefficients re-
placed by the estimates obtained under the null
model was employed. The equation estimated
was:
y; aX %
4
j2
bjyˆ jei (2)
where yˆ denotes the fitted value under the null
model. For a more detailed description of the test,
see Godfrey [15].
The results of the test are presented in Table 4.
The first line of the table presents the variables
that were included in each regression. For exam-
ple, in the third column, only the constant term,
the GDP growth rate and the initial value of per
capita expenditures were included.
The results show that there is a clear misspecifi-
cation problem in the regression without the
quadratic term in the initial position, while this is
no longer true in the other two cases (the likeli-
hood ratio test does not reject the null hypothesis
of no misspecification).
Table 5. Exogeneity tests
Const. 5.0348.588
(5.07) (2.97)
GDPGR 0.457 0.811
(1.73) (2.61)
0.110y–T 0.038
(2.83)(4.60)
0.038y2–T
(3.43)
z 0.420 0.248
(0.49)(0.97)
Adjusted R2 0.696070 0.622504
Log. Likelihood 174.228 167.146
Test for exogeneity of GDP growth
From the set of exogenous variables, one may
argue that GDP growth is not exogenous. To test
for it, a type of ‘omitted variables’ test was per-
formed. (For the details, see Godfrey [15].) The
regression equation was augmented by the resid-
ual estimate of the value of GDP growth on a set
of instruments. The instruments were GDP level
(at the end of previous period), country dummies
and health expenditure to GDP at the end of
previous period.
As the statistical significance of z is low (the
coefficient is not statistically different from zero),
we conclude that the hypothesis of exogeneity is
not rejected (Table 5).
Non-normality tests
Finally, we also tested for non-normal error
terms, using the statistic:
Table 4. RESET tests
Variables (const, GDPGR, y–T) y
2
–T, D9080 y
2
–T
bj0
0.704275Adjusted R2 0.710380 0.626903
Log. likelihood 175.618 174.198 166.999
bj"0
0.6907700.707533Adjusted R2 0.714051
175.268177.645 174.613Log. likelihood
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where S is skewness and k is kurtosis of the
residual. The main inference from application of
the test to the various regressions is that we do
not reject the null hypothesis of normality. For
example, for the maintained model, S 0.558,
k3.744, the value of the statistic being 4.87,
which is below the critical level of the x2 distribu-
tion with two degrees of freedom, at the usual 5%
significance level (which is 5.99).
APPENDIX B: FURTHER ESTIMATES
The reader may ask how much of the results is
dependent on the use of 10-year average growth
rates. To cope with that question, Table 6 pre-
sents estimates based on 5-year average growth
rates. Similarly, Table 7 reports estimates using
year-to-year average growth rates. (Data for all
countries and periods was not available. The most
complete set of data available was used.) In the
former case, as we consider a 5-year period, quin-
Table 6. Five-year average growth rate estimates
Growth rate of health expenditures per capita
4.37Const. 4.287.33 6.88 5.33
(3.23)(4.29) (3.96) (2.72) (2.53)
0.880.760.79 0.960.68GDPGR
(3.57)(2.52) (3.03) (2.45) (2.71)
PR 0.72 0.61
(0.85)(0.99)
PI 0.660.54
(0.80) (0.94)
GK 0.13 0.33
(0.22) (0.58)
1.50 1.28D7065
(1.27) (1.04)
D7570 2.08 1.75
(1.70) (1.41)
0.450.004D8075
(0.04) (0.37)
1.63 0.81D8580 1.03
(0.57) (0.73)(2.62)
0.29 0.441.09D9085
(1.75) (0.21) (0.32)
AGE65 0.18 0.11
(0.43) (0.25)
0.100.09PUBFIN
(0.40) (0.49)
0.0300.0240.0840.0880.083TE per capita–T
(3.57)(3.87)(3.82) (3.23) (3.53)
(TE per capita–T)
2 0.030 0.030 0.032
(3.10) (3.21) (2.75)
Adjusted R2 0.4810.496 0.511 0.468 0.441
125125Number of obs. 125125125
The values shown in parenthesis are t-ratios, based on White’s robust S.E.s.
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Table 7. Year-to-year average growth rate estimates
Growth rate of health expenditures per capita
Const. 0.09 0.09 0.08 0.08 0.07
(6.57) (6.30) (4.09) (4.08) (7.09)
GDPGR 0.27 0.33 0.26 0.30 0.39
(2.23) (2.69) (2.14) (2.49) (3.32)
PR 0.87 0.76
(1.49) (1.28)
PI 0.36 0.49
(0.60) (0.80)
GK 0.23 0.38
(0.47) (0.77)
D8090 0.18 0.21 0.23
(3.54) (2.01) (2.15)
D7080 0.03 0.07
(0.37) (0.76)
AGE65 0.24 0.92
(0.02) (0.06)
PUBFIN 0.19 0.11
(0.79) (0.51)
TE per capita–T 0.088 0.098 0.092 0.030 0.038
(4.08) (4.63) (4.31) (3.75) (5.51)
(TE per capita–T)
2 0.029 0.030 0.031
(3.83) (3.90) (3.67)
Adjusted R2 0.164 0.148 0.155 0.151 0.127
Number of obs. 614 614 614 614 614
The values shown in parenthesis are t-ratios, based on White’s robust S.E.s.
quennial dummy variables were included. Com-
parison with Table 1 reveals the same qualitative
features are common to all sets of estimates.
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